Evidence-based communication strategies remain the forte of Medical Affairs but highlighting the right data in the right context remains a challenge to proving authenticity. What’s more with healthcare stakeholders increasing demanding transparency around all activities, delivering authenticity has never been more important.

We explored this challenge, and the opportunities it brings about in our latest whitepaper, Authenticity in Medical Affairs. You can download this whitepaper here –

Access this paper and you'll receive the following insights:

• Monica de Abadal, VP, Global Medical Affairs Services (Deputy Chief Medical Officer), Ipsen speaking about why communicating data to external stakeholders is essential to Ipsen’s medical affairs strategy,

• Shontelle Dodson, SVP, Medical Affairs, Americas, Astellas Pharma explaining why early collaboration and cooperation between medical and commercial is essential to deliver on key objectives

• Kirk V. Shepard, SVP, Global Medical Affairs Oncology, Eisai on how he has implemented an insight collection process to analyze insights and assess the knowledge should go for optimum decision-making.

...and more.

Download this paper here.

Best regards,

Josh Bramwell
Director, Medical Affairs


This email advertisement was sent on behalf of eyeforpharma by HealthEconomics.Com, 449 S. Mill View Way, Ponte Vedra Beach, FL 32082.
If you don't wish to receive further Industry Leaders News Updates from us, you may immediately unsubscribe from this list here , or send your request in writing to the address above. Read more about our privacy policy here. You may also request a copy in writing using the address above.